Related Experiment Videos
Polymyxin B nonapeptide inhibits mating in Saccharomyces cerevisiae
Antimicrobial Agents and Chemotherapy
|February 1, 1986
Abstract:
Polymyxin B nonapeptide enhanced susceptibility of yeast cells to various hydrophobic antibiotics and to mating pheromones. At much lower concentrations, the nonapeptide severely inhibited mating. The inhibition was caused by interference with sexual agglutination.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The application of nanocrystaline diamond coatings in medicine.
Ortopedia, traumatologia, rehabilitacja·2007
High-efficiency transient transfection of endothelial cells for functional analysis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2000
Sphingosylphosphorylcholine induces endothelial cell migration and morphogenesis.
Biochemical and biophysical research communications·2000
Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways.
The Journal of biological chemistry·2000
Impact of renal impairment on pharmacokinetics, safety, and tolerability of funobactam, combined with imipenem and cilastatin.
Antimicrobial agents and chemotherapy·2026
Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections.
Antimicrobial agents and chemotherapy·2026
IS26-mediated circular blaKPC transposon in ST2483 Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
A chloramine-based antiseptic polymer improves Candida auris skin decolonization compared to chlorhexidine in a murine model.
Antimicrobial agents and chemotherapy·2026
In vivo emergence of ceftazidime/avibactam resistance in Pseudomonas aeruginosa driven by OXA-1381, a novel W157L Ω-loop variant of OXA-2.
Antimicrobial agents and chemotherapy·2026
Wogonoside: Pharmacology, molecular targets and therapeutic potential.
Biochemical pharmacology·2026
Glycosylation switches spiramycin from an antibiotic to a hepatoprotective agent by targeting GSTP1.
Bioorganic chemistry·2026